药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Dimethyltryptamine
Pheniramine
The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Glasdegib.
Dimethyltryptamine
Solifenacin
The risk or severity of QTc prolongation can be increased when Solifenacin is combined with Glasdegib.
Dimethyltryptamine
Encorafenib
The risk or severity of QTc prolongation can be increased when Encorafenib is combined with Glasdegib.
Dimethyltryptamine
Ivosidenib
The risk or severity of QTc prolongation can be increased when Ivosidenib is combined with Glasdegib.
Dimethyltryptamine
Dexverapamil
The risk or severity of QTc prolongation can be increased when Dexverapamil is combined with Glasdegib.
Dimethyltryptamine
Penfluridol
The risk or severity of QTc prolongation can be increased when Penfluridol is combined with Glasdegib.
Dimethyltryptamine
Dexchlorpheniramine
The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine is combined with Glasdegib.
Dimethyltryptamine
Lorcainide
The risk or severity of QTc prolongation can be increased when Lorcainide is combined with Glasdegib.
Dimethyltryptamine
Bunaftine
The risk or severity of QTc prolongation can be increased when Bunaftine is combined with Glasdegib.
Dimethyltryptamine
Nizofenone
The risk or severity of QTc prolongation can be increased when Nizofenone is combined with Glasdegib.
Dimethyltryptamine
Otilonium
The risk or severity of QTc prolongation can be increased when Otilonium is combined with Glasdegib.
Dimethyltryptamine
Sultopride
The risk or severity of QTc prolongation can be increased when Sultopride is combined with Glasdegib.
Dimethyltryptamine
Sitafloxacin
The risk or severity of QTc prolongation can be increased when Sitafloxacin is combined with Glasdegib.
Dimethyltryptamine
Oxatomide
The risk or severity of QTc prolongation can be increased when Oxatomide is combined with Glasdegib.
Dimethyltryptamine
Abexinostat
The risk or severity of QTc prolongation can be increased when Abexinostat is combined with Glasdegib.
Dimethyltryptamine
Mizolastine
The risk or severity of QTc prolongation can be increased when Mizolastine is combined with Glasdegib.
Dimethyltryptamine
Ricolinostat
The risk or severity of QTc prolongation can be increased when Ricolinostat is combined with Glasdegib.
Dimethyltryptamine
Simendan
The risk or severity of QTc prolongation can be increased when Simendan is combined with Glasdegib.
Dimethyltryptamine
CUDC-101
The risk or severity of QTc prolongation can be increased when CUDC-101 is combined with Glasdegib.
Dimethyltryptamine
Gilteritinib
The risk or severity of QTc prolongation can be increased when Gilteritinib is combined with Glasdegib.